Cargando…

Proton pump inhibitors in the COVID-19 pandemic()

Detalles Bibliográficos
Autor principal:	Sebastián Domingo, Juan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437757/ http://dx.doi.org/10.1016/j.gastre.2021.04.003

Ejemplares similares

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Los inhibidores de la bomba de protones en la pandemia por la COVID-19
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Can proton pump inhibitors cause intestinal inflammation in children?
por: Kang, Ben
Publicado: (2019)

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment
por: Chen, Hao, et al.
Publicado: (2023)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
por: Graham, David Y., et al.
Publicado: (2017)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang, Xiao-Yu, et al.
Publicado: (2021)

COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022)

Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?
por: Ge, Ruiguang
Publicado: (2012)

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
por: Lee, Chansu, et al.
Publicado: (2016)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
por: Taştemur, Şeyma, et al.
Publicado: (2020)

Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Cho, Yu Kyung
Publicado: (2014)

Do Proton Pump Inhibitor–refractory Laryngeal Symptoms Represent a True Acid-related Disease?
por: Hong, Kwon-Eui, et al.
Publicado: (2023)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections
por: Price, Elizabeth, et al.
Publicado: (2021)

Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021)

Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
por: Wu, Shengyong, et al.
Publicado: (2022)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
por: Kishore, E, et al.
Publicado: (2023)

Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
por: Tan, Hui Zhuan, et al.
Publicado: (2023)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9uq30gdj8jucuhq3c8g2299lf